drugset / Trial / NCT02831192

Microtransplantation in Older Patients With Acute Myeloid Leukemia

NCT02831192

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to see whether HLA-mismatched donor cells infusion with chemotherapy (microtransplantation,MST) could increase complete remission (CR) and improve survival in older patients with acute myeloid leukemia (AML),the investigators conducted a prospective, multicenter clinical trial of HLA-mismatched MST to estimate outcomes and toxicities.

Timeline

Start
2006-05
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Microtransplantation Cell therapy